Fierce Biotech

Subscribe to Fierce Biotech feed
Updated: 4 hours 15 min ago

'Gateway to China' Zai Lab aims for $750M to bankroll licensing deals, clinical trials

Tue, 04/20/2021 - 11:22
'Gateway to China' Zai Lab aims for $750M to bankroll licensing deals, clinical trials aalidrus Tue, 04/20/2021 - 14:22

Janssen taps PhysIQ's AI platform to make wearable sensor data more useful

Tue, 04/20/2021 - 08:49
Janssen taps PhysIQ's AI platform to make wearable sensor data more useful apark Tue, 04/20/2021 - 11:49

Abbott, J&J post rebounds in surgical sales, while COVID testing remains a cash cow for now

Tue, 04/20/2021 - 07:12
Abbott, J&J post rebounds in surgical sales, while COVID testing remains a cash cow for now chale Tue, 04/20/2021 - 10:12

Church joins the NFT craze with plans to auction off his genome

Tue, 04/20/2021 - 06:51
Church joins the NFT craze with plans to auction off his genome apark Tue, 04/20/2021 - 09:51

Gossamer Bio CSO hits the exit after turbulent year, research exec steps up

Tue, 04/20/2021 - 06:20
Gossamer Bio CSO hits the exit after turbulent year, research exec steps up aalidrus Tue, 04/20/2021 - 09:20

Vertex takes the lead in CRISPR Therapeutics partnership with $900M upfront

Tue, 04/20/2021 - 05:43
Vertex takes the lead in CRISPR Therapeutics partnership with $900M upfront aarmstrong Tue, 04/20/2021 - 08:43

KalVista hit with a clinical hold on 2nd asset as fortunes ebb and flow

Tue, 04/20/2021 - 03:59
KalVista hit with a clinical hold on 2nd asset as fortunes ebb and flow badams Tue, 04/20/2021 - 06:59

Forbion closes final European life sciences funding round at €360M with help from Eli Lilly

Tue, 04/20/2021 - 01:17
Forbion closes final European life sciences funding round at €360M with help from Eli Lilly badams Tue, 04/20/2021 - 04:17

PPD-backed siteless trial specialist Medable reels in $78M as the pandemic continues to push its biz forward

Tue, 04/20/2021 - 00:43
PPD-backed siteless trial specialist Medable reels in $78M as the pandemic continues to push its biz forward badams Tue, 04/20/2021 - 03:43

Ovid dumps lead program after lackluster showing in Angelman syndrome

Mon, 04/19/2021 - 12:38
Ovid dumps lead program after lackluster showing in Angelman syndrome aalidrus Mon, 04/19/2021 - 15:38

Virta Health hits $2B valuation with $133M funding to expand reach of diabetes-reversing platform

Mon, 04/19/2021 - 10:06
Virta Health hits $2B valuation with $133M funding to expand reach of diabetes-reversing platform apark Mon, 04/19/2021 - 13:06

Facebook unveils AI model to mix up cancer-curing cocktails with existing drugs

Mon, 04/19/2021 - 07:51
Facebook unveils AI model to mix up cancer-curing cocktails with existing drugs apark Mon, 04/19/2021 - 10:51

CVS, Walgreens begin rolling out over-the-counter COVID tests from Abbott, Ellume and more

Mon, 04/19/2021 - 07:39
CVS, Walgreens begin rolling out over-the-counter COVID tests from Abbott, Ellume and more chale Mon, 04/19/2021 - 10:39

Zymeworks' first CMO moves on as lead cancer candidate heads for commercialization

Mon, 04/19/2021 - 06:58
Zymeworks' first CMO moves on as lead cancer candidate heads for commercialization aarmstrong Mon, 04/19/2021 - 09:58

Rejuvenate Bio banks $10M to advance gene therapy for aging in humans and dogs

Mon, 04/19/2021 - 06:54
Rejuvenate Bio banks $10M to advance gene therapy for aging in humans and dogs aalidrus Mon, 04/19/2021 - 09:54

Medtronic taps IoT security startup Sternum to prevent pacemaker hacks

Mon, 04/19/2021 - 06:08
Medtronic taps IoT security startup Sternum to prevent pacemaker hacks apark Mon, 04/19/2021 - 09:08

Epizyme's EZH2 blocker boosts immuno-oncology response in prostate cancer models

Mon, 04/19/2021 - 06:02
Epizyme's EZH2 blocker boosts immuno-oncology response in prostate cancer models arlene.weintraub Mon, 04/19/2021 - 09:02

Lumicks snags $93M for its molecular tweezers and cell therapy hardware

Mon, 04/19/2021 - 05:53
Lumicks snags $93M for its molecular tweezers and cell therapy hardware chale Mon, 04/19/2021 - 08:53

Adagio raises a monster $336M round for bespoke COVID-19 drug battle

Mon, 04/19/2021 - 03:59
Adagio raises a monster $336M round for bespoke COVID-19 drug battle badams Mon, 04/19/2021 - 06:59

3 very different biotechs all file for the same IPO goal: A big raise on Nasdaq

Mon, 04/19/2021 - 01:05
3 very different biotechs all file for the same IPO goal: A big raise on Nasdaq badams Mon, 04/19/2021 - 04:05